Study Plan of AlzeCure's Phase II Clinical Study in Neuropathic Pain with Non-Opioid ACD440 Now Available - Digital Journal
6/15/2022 12:00:00 AM2 years 10 months ago
by ACCESSWIRE
by ACCESSWIRE
STOCKHOLM, SE / ACCESSWIRE / June 15, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company
STOCKHOLM, SE / ACCESSWIRE / June 15, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candi… [+4787 chars]
full article...